Also Known As:
UGT1A1 Gene Polymorphism (Irinotecan Dosage)UGT1A1
The UGT1A1 Gene Polymorphism (Irinotecan Dosage) test is carefully performed at our center to ensure precise and reliable results. The UGT1A1 gene polymorphism affects the metabolism of irinotecan, a chemotherapy drug. Testing for UGT1A1 gene status helps optimise irinotecan dosing to help improve treatment outcomes.
Includes 1 Test Parameters
Test Preparation:
No Special Preparation. Informed Consent Required.
Reporting TAT:
24 Hours